Share

CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

You are invited to attend a press briefing at the European Association for the Study of Diabetes (EASD) 1999

Tuesday 28 September 1999, 18.30 - 20:00,
Ambassador Room, 1st Floor, Hall 10
Brussels Exhibition and Conference Centre

What is the cost of type 2 diabetes in Europe?
How do different countries compare?
Are current management strategies effective?
Why is insulin resistance important?
Could new approaches save lives and money?

CODE-2* is the first pan-European study to evaluate the economic impact of type 2 diabetes on society.

8 European countries
Over 600 physicians
Over 7000 patients

The press briefing, hosted by members of CODE-2* Advisory Boards, will launch the results of this landmark study and discuss the implications of CODE-2* for the future treatment of type 2 diabetes.

The following CODE-2* experts will speak at the briefing:

• Professor Massimo Massi-Benedetti
  Chair of the International Diabetes Foundation (Europe Region), Italy

• Professor Bengt Jönsson
  Stockholm School of Economics, Sweden

• Dr Andreas Liebl
  Staedtisches Krankenhaus Bogenhausen, Germany

• Dr Robert Young
  Hope Hospital, Salford, UK

To confirm your attendance at the briefing, please contact Barbara Campbell, Susie Hackett or Kate Davies on: Tel: 44-171-404-7151
Email:
barbarac@meditech.co.uk
kate@meditech.co.uk
susie@meditech.co.uk

SmithKline Beecham Pharmaceuticals -- Advancing Diabetes Care

*Trademark of SmithKline Beecham plc (CODE-2: Costs of Diabetes in Europe -- Type 2)

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.